Capturing the aversive state of cephalic pain preclinically.
about
CGRP as a neuropeptide in migraine: lessons from micePain-related depression of the mesolimbic dopamine system in rats: expression, blockade by analgesics, and role of endogenous κ-opioids.Function and postnatal changes of dural afferent fibers expressing TRPM8 channels.Chronic pain induces generalized enhancement of aversionCorticostriatal Regulation of Acute PainIncreased susceptibility to cortical spreading depression in an animal model of medication-overuse headacheModelling headache and migraine and its pharmacological manipulationTargeting TRP channels for novel migraine therapeutics.Reward and motivation in pain and pain reliefDescending pain modulation and chronification of pain.Neuroplasticity underlying the comorbidity of pain and depressionActivation of corticostriatal circuitry relieves chronic neuropathic pain.Persistent pain alters AMPA receptor subunit levels in the nucleus accumbensBehavioral and neurochemical analysis of ongoing bone cancer pain in rats.A possible neural mechanism for photosensitivity in chronic painAn overview of animal models of pain: disease models and outcome measures.Efficacy of (S)-Lacosamide in preclinical models of cephalic pain.The role of calcitonin gene-related peptide in peripheral and central pain mechanisms including migraine.Does the kappa opioid receptor system contribute to pain aversion?Positive emotions and brain reward circuits in chronic pain.Modulation of pain, nociception, and analgesia by the brain reward center.Brain network alterations in the inflammatory soup animal model of migraine.From blast to bench: A translational mini-review of posttraumatic headache.Reward, motivation, and emotion of pain and its relief.Sustained relief of ongoing experimental neuropathic pain by a CRMP2 peptide aptamer with low abuse potential.Dural stimulation in rats causes brain-derived neurotrophic factor-dependent priming to subthreshold stimuli including a migraine trigger.Activation of mesocorticolimbic reward circuits for assessment of relief of ongoing pain: a potential biomarker of efficacy.Nerve injury induced activation of fast-conducting high threshold mechanoreceptors predicts non-reflexive pain related behavior.Characterization of a mouse model of headacheCranial dural permeability of inflammatory nociceptive mediators: Potential implications for animal models of migraine.[EXPRESS] PolyMorphine provides extended analgesic-like effects in mice with spared nerve injury.Epoxy fatty acids mediate analgesia in murine diabetic neuropathy.Soluble guanylyl cyclase is a critical regulator of migraine-associated pain.Dopamine D2/D3 imbalance during migraine attack and allodynia in vivo.Ketamine reduces aversion in rodent pain models by suppressing hyperactivity of the anterior cingulate cortexInhibition of the Prefrontal Projection to the Nucleus Accumbens Enhances Pain Sensitivity and Affect
P2860
Q26821821-5531D518-F43B-464B-8ECF-CBB70D1A7592Q30565476-5753D6F0-D655-4390-BFE4-C4C3FD127E22Q30655668-67AE2237-E97C-41CF-9165-3FA4C51CDC7AQ33708197-25870C5C-261B-485B-8F4C-3E8A6F304624Q33729320-2CABE1E9-2274-4206-AD51-EE625BB17C5EQ33921986-CE56293B-50A9-4A67-A0C8-B9CE05659306Q34407137-E8DD6AF9-A009-44AB-8795-7ABB48C1BE6BQ34555756-390B5009-8F46-455F-81D4-0AAC8E84ACA9Q34993445-2F4D6C9A-0802-465D-B666-9F64612CFFBAQ34993456-07C1D4B9-CEFB-4A9F-A7AA-72B1EAB32352Q35165267-A8411D73-D800-4FD3-965A-97B8FE425D75Q35236871-90E48830-1735-4430-9E6C-191B64D08E5BQ35938248-61F8F723-4BEE-4671-BEB2-90BB9A5EDAF8Q36083409-371E5883-A943-4BEA-9C4A-62A1179F4CC2Q36693261-E36D604D-F361-4B17-B811-158AF91589BFQ37282107-6BD2F091-7586-4894-875C-FEC81E614275Q37451570-FC1976B3-CCDA-48CB-9AFA-AE823E2DF227Q37713262-BFED65E5-47EE-4A8A-B26C-87A79A15ADBEQ38276410-6E38D254-8B43-42C4-B524-5D6C3BB12772Q38703803-017E7FB6-A13B-4247-BB19-96DA57E72D39Q38836955-DE7D14CD-EE4B-48B9-91C4-9112316C928FQ38975819-360567B2-1D81-4E27-AB20-07D6307944ADQ39115339-8C39B424-4213-42BA-9366-B3EFF26AEA9BQ39160909-79F663AA-6FA5-458C-90D1-420A1CFB193AQ39168504-1F2BFBE6-1C6C-4203-8916-4C2E1492F68BQ39189729-827A82E1-39FF-4826-B832-26F59F9643B4Q39206528-FBFA01D6-31FF-48C1-B278-047A01355026Q39470957-96155A77-6F3B-4A30-95F2-3659B3EDAA31Q42175618-DC14D637-0F81-4FEB-839E-3E616E166EE6Q45296700-FDDCD968-AF26-4187-B388-1039F24493FBQ45480815-0436272F-5AD9-4B78-9B5A-842567FB98B3Q46708671-E240A48E-8C03-4635-9D3C-FF97852D0457Q48023073-9A38792E-C933-4196-A47B-E1749E59D3FFQ48239069-208388BD-3B3D-4744-B6B9-276110F5AE9FQ58740675-5083450E-8F9F-46E3-8C44-D63E7528674CQ58785862-98B811F8-C2CF-447B-9C72-213E166E5FD5
P2860
Capturing the aversive state of cephalic pain preclinically.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Capturing the aversive state of cephalic pain preclinically.
@en
Capturing the aversive state of cephalic pain preclinically.
@nl
type
label
Capturing the aversive state of cephalic pain preclinically.
@en
Capturing the aversive state of cephalic pain preclinically.
@nl
prefLabel
Capturing the aversive state of cephalic pain preclinically.
@en
Capturing the aversive state of cephalic pain preclinically.
@nl
P2093
P2860
P356
P1433
P1476
Capturing the aversive state of cephalic pain preclinically.
@en
P2093
Frank Porreca
Gregory O Dussor
Howard L Fields
Michael H Ossipov
Milena De Felice
Nathan Eyde
P2860
P304
P356
10.1002/ANA.23922
P577
2013-08-01T00:00:00Z